Tag Archives: Pays

Biohaven’s ambitious Nurtec ODT marketing strategy pays dividends with doctors in migraine market: analyst

Biohaven went all-in on marketing its added preventative indication for oral migraine med Nurtec. And now it’s reaping the rewards with doctors. Three months post-approval, 96% of neurologists were aware of the brand, while 65% are “highly familiar” with it, according to Spherix Global Insights’ postlaunch report. Nurtec easily bested bigger migraine players postlaunch familiarity including Amgen’s… Read More »

Bausch pays whopping $300M to settle Glumetza pay-for-delay lawsuit after 800% price hike

Bausch Health, which industry watchers may remember by its former name Valeant, has been riddled in controversy for years over its defense of diabetes med Glumetza. Now, the company will pay millions to put those charges to rest.  Bausch has agreed to dish out $ 300 million to settle a 2019 lawsuit that claimed the Canadian drugmaker… Read More »

Pfizer, riding high on COVID-19 vaccine launch, pays CEO Bourla $21 million for 2020

Thanks to the success of its COVID-19 vaccine, the drug giant Pfizer has become a household name around the globe—and the company’s eyeing $ 15 billion in sales from the shot this year. For writing that 2020 success story, CEO Albert Bourla collected a pay package worth more than $ 21 million. Bourla, who took… Read More »